NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases)
Scientific/Medical - Clinical Care
Group Awards
NIDDK iPSC Protocol Group
For developing protocol to generate human iPSC-derived, glucose responsive beta cells to explore the mechanism of therapies for gene variants contributing to type-2 diabetes.